Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival (rPFS) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302

被引：0
|
作者：
Ryan, Charles J.
Londhe, Anil
Molina, Arturo
Smith, Matthew R.
De Bono, Johann Sebastian
Mulders, Peter
Rathkopf, Dana E.
Saad, Fred
Logothetis, Christopher
Fizazi, Karim
Scher, Howard I.
Small, Eric Jay
Matheny, Shannon
Kheoh, Thian San
Griffin, Thomas W.
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Janssen Res & Dev LLC, Raritan, NJ USA
[3] Janssen Res & Dev LLC, Los Angeles, CA USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[5] Royal Marsden NHS Fdn Trust, Inst Canc Res, Sutton, Surrey, England
[6] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[8] Univ Montreal, Montreal, PQ, Canada
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[10] Univ Paris 11, Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5010
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of prior endocrine therapy on radiographic progression-free survival (rPFS) in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
    Oudard, Stephane
    Kheoh, Thian San
    Yu, Margaret K.
    Smith, Matthew R.
    Small, Eric Jay
    Mulders, Peter F. A.
    Fizazi, Karim
    Rathkopf, Dana E.
    Saad, Fred
    Scher, Howard I.
    Bellmunt, Joaquim
    Taplin, Mary-Ellen
    Davis, Ian D.
    Schrijvers, Dirk L.
    Protheroe, Andrew
    Molina, Arturo
    Griffin, Thomas W.
    De Bono, Johann Sebastian
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [2] Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results
    Morris, Michael J.
    Molina, Arturo
    Small, Eric J.
    de Bono, Johann S.
    Logothetis, Christopher J.
    Fizazi, Karim
    de Souza, Paul
    Kantoff, Philip W.
    Higano, Celestia S.
    Li, Jinhui
    Thian Kheoh
    Larson, Steven M.
    Matheny, Shannon L.
    Naini, Vahid
    Burzykowski, Tomasz
    Griffin, Thomas W.
    Scher, Howard I.
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1356 - +
  • [3] Association of alkaline phosphatase with clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): results from COU-AA-302
    Mainwaring, P.
    Yu, E. Y.
    Londhe, A.
    Van Poppel, H.
    Rathkopf, D. E.
    Smith, M. R.
    Souza, P.
    Griffin, T. W.
    Ryan, C. J.
    BJU INTERNATIONAL, 2014, 113 : 21 - 21
  • [4] Prognostic value of PSA progression in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated in the COU-AA-302 trial.
    Lorente, David
    Lozano, Rebeca
    de Velasco, Guillermo
    De Julian, Maria
    Rodrigo, Miguel
    Sanchez, Angel L.
    Di Capua, Carlos
    Castro, Elena
    Sanchez Hernandez, Alfredo
    Olmos, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Association of alkaline phosphatase (ALP) with clinical outcomes in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
    Yu, Evan Y.
    Saad, Fred
    Londhe, Anil
    Shore, Neal D.
    Van Poppel, Hendrik
    Rathkopf, Dana E.
    Smith, Matthew R.
    Logothetis, Christopher
    De Souza, Paul L.
    Fizazi, Karim
    Mulders, Peter F. A.
    Mainwaring, Paul N.
    Hainsworth, John D.
    Beer, Tomasz M.
    North, Scott A.
    Small, Eric Jay
    Scher, Howard I.
    Griffin, Thomas W.
    Yu, Margaret K.
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [6] Radiographic progression-free survival (rPFS) and time to radiographic progression (TTrP) as surrogate endpoints in docetaxel-naive metastatic castrate resistant prostate cancer (mCRPC): A pooled analysis of COU-AA-302 and ACIS.
    Roy, Soumyajit
    Sun, Yilun
    Spratt, Daniel Eidelberg
    Morgan, Scott C.
    Kim, Thomas
    Malone, Julia
    Wallis, Christopher J. D.
    Kishan, Amar Upadhyaya
    Saad, Fred
    Malone, Shawn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Final analysis of the randomised, phase 3, COU-AA-302 study of abiraterone acetate (AA) in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC)
    De Souza, P.
    Smith, M. R.
    Fizazi, K.
    Saad, F.
    Mulders, P. F. A.
    Sternberg, C. N.
    Miller, K.
    Logothetis, C. J.
    Shore, N.
    Small, E. J.
    Carles, J.
    Flaig, T. W.
    Taplin, M-E.
    Higano, C. S.
    De Bono, J. S.
    Griffin, T. W.
    De Porre, P.
    Yu, M. K.
    Park, Y. C.
    Li, J.
    Kheoh, T.
    Naini, V.
    Molina, A.
    Rathkopf, D. E.
    Ryan, C. J.
    BJU INTERNATIONAL, 2015, 115 : 21 - 22
  • [8] Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Ryan, Charles J.
    Smith, Matthew Raymond
    De Bono, Johann Sebastian
    Molina, Arturo
    Logothetis, Christopher
    De Souza, Paul L.
    Fizazi, Karim
    Mainwaring, Paul N.
    Piulats Rodriguez, Jose Maria
    Ng, Siobhan
    Carles, Joan
    Mulders, Peter
    San Kheoh, Thian
    Griffin, Thomas W.
    Small, Eric Jay
    Scher, Howard I.
    Rathkopf, Dana E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] IMPACT OF PRIOR ENDOCRINE THERAPY ON CLINICAL BENEFIT OF ABIRATERONE ACETATE IN PATIENTS WITH CHEMOTHERAPY-NAIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM COU-AA-302
    Saad, Fred
    Kheoh, Thian
    Yu, Margaret K.
    Smith, Matthew R.
    Small, Eric J.
    Mulders, Peter F. A.
    Fizazi, Karim
    Rathkopf, Dana
    Oudard, Stephane
    Scher, Howard I.
    Bellmunt, Joaquim
    Taplin, Mary-Ellen
    Davis, Ian D.
    Schrijvers, Dirk
    Protheroe, Andrew
    Molina, Arturo
    Griffin, Thomas W.
    de Bono, Johann S.
    Ryan, Charles J.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E810 - E810
  • [10] Prognostic index for progression-free survival in metastatic castration-resistant prostate cancer patients without previous chemotherapy: An analysis of the COU-AA-302 abiraterone acetate study
    Ryan, C. J.
    Kheoh, T.
    Molina, A.
    Carles, J.
    Efstathiou, E.
    Kantoff, P. W.
    Mulders, P. F. A.
    Saad, F.
    Griffin, T.
    Chi, K. N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S683 - S684
12345